Effects of PS-341 on the activity and composition of proteasomes in multiple myeloma cells.

Effects of PS-341 on the activity and composition of proteasomes in multiple myeloma cells.

Multiple myeloma is a B-cell malignancy for which no curative therapies exist to date, despite enormous research efforts. The remarkable activity of the proteasome inhibitor bortezomib (PS-341, Velcade) observed in clinical trials of patients with relapsed refractory myeloma has led to investigation...

書誌詳細
主要な著者:	Altun, M, Galardy, P, Shringarpure, R, Hideshima, T, LeBlanc, R, Anderson, K, Ploegh, H, Kessler, B
フォーマット:	Journal article
言語:	English
出版事項:	2005

類似資料

Dendritic cells efficiently internalize and process exogenous peptides despite proteasome inhibition.
著者:: LeBlanc, R, 等
出版事項: (2002)

Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib.
著者:: Berkers, C, 等
出版事項: (2005)

Myeloma cells exhibit an increase in proteasome activity and an enhanced response to proteasome inhibition in the bone marrow microenvironment in vivo.
著者:: Edwards, C, 等
出版事項: (2009)

Detection of ubiquitin-proteasome enzymatic activities in cells: application of activity-based probes to inhibitor development.
著者:: Kramer, H, 等
出版事項: (2012)

Detection of ubiquitin-proteasome enzymatic activities in cells: Application of activity-based probes to inhibitor development
著者:: Kramer, H, 等
出版事項: (2012)

Investigating Effects of Proteasome Inhibitor on Multiple Myeloma Cells Using Confocal Raman Microscopy
著者:: Kang, Jeon Woong, 等
出版事項: (2017)

LMP2 expression and proteasome activity in NOD mice.
著者:: Kessler, B, 等
出版事項: (2000)

LMP2 expression and proteasome activity in NOD mice
著者:: Kessler, B, 等
出版事項: (2000)

The ubiquitin-proteasome pathway is dysregulated in myeloma cells in the bone microenvironment in vivo
著者:: Edwards, C, 等
出版事項: (2007)

Chemistry in living cells: detection of active proteasomes by a two-step labeling strategy.
著者:: Ovaa, H, 等
出版事項: (2003)

Integration of the ubiquitin-proteasome pathway with a cytosolic oligopeptidase activity.
著者:: Wang, E, 等
出版事項: (2000)

Tight metabolic coupling of the proteasome with downstream oligopeptidases.
著者:: Wang, E, 等
出版事項: (1999)

Muscle wasting in aged, sarcopenic rats is associated with enhanced activity of the ubiquitin proteasome pathway.
著者:: Altun, M, 等
出版事項: (2010)

Extended peptide-based inhibitors efficiently target the proteasome and reveal overlapping specificities of the catalytic beta-subunits.
著者:: Kessler, B, 等
出版事項: (2001)

A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance.
著者:: Chauhan, D, 等
出版事項: (2012)

A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14.
著者:: Borodovsky, A, 等
出版事項: (2001)

Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib.
著者:: Shringarpure, R, 等
出版事項: (2006)

Cks1 activates transcription by binding to the ubiquitylated proteasome.
著者:: Holic, R, 等
出版事項: (2010)

IS THE INCIDENCE OF MULTIPLE-MYELOMA REALLY INCREASING
著者:: Velez, R, 等
出版事項: (1981)

Animal models of multiple myeloma
著者:: Olechnowicz, SWZ, 等
出版事項: (2019)

Bisphosphonates--mechanisms of action in multiple myeloma.
著者:: Shipman, C, 等
出版事項: (2000)

Solid phase synthesis of peptide vinyl sulfone and peptide epoxyketone proteasome inhibitors
著者:: Overkleeft, H, 等
出版事項: (2000)

Impact of prior lenalidomide or proteasome inhibitor exposure on the effectiveness of ixazomib–lenalidomide–dexamethasone for relapsed/refractory multiple myeloma: A pooled analysis from the INSURE study
著者:: Lee, HC, 等
出版事項: (2024)

Subunit-selective proteasome activity profiling uncovers uncoupled proteasome subunit activities during bacterial infections
著者:: Misas-Villamil, J, 等
出版事項: (2017)

Genomic patterns of progression in smoldering multiple myeloma
著者:: Bolli, N, 等
出版事項: (2018)

Myeloma cells isolated from patients with multiple myeloma express osteoprotegerin ligand.
著者:: Shipman, C, 等
出版事項: (2000)

Bone marrow adiposity and multiple myeloma
著者:: Morris, E, 等
出版事項: (2018)

The Bone Marrow Microenvironment in Multiple Myeloma
著者:: Edwards, C
出版事項: (2010)

The pathogenesis of the bone disease of multiple myeloma.
著者:: Edwards, C, 等
出版事項: (2008)

The role of BMP signalling in multiple myeloma
著者:: Gooding, S
出版事項: (2018)

Lysine demethylase 5A is required for MYC-driven transcription in multiple myeloma
著者:: Ohguchi, H, 等
出版事項: (2021)

Initial genome sequencing and analysis of multiple myeloma
著者:: Chapman, Michael A., 等
出版事項: (2014)

Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
著者:: Kurata, K, 等
出版事項: (2023)

Role of the proteasome and non proteasomal proteases in the generation of CTL epitopes.
著者:: Cerundolo, V, 等
出版事項: (1998)

A cell-permeable inhibitor and activity-based probe for the caspase-like activity of the proteasome.
著者:: van Swieten, P, 等
出版事項: (2007)

Bisphosphonates and in vivo models of multiple myeloma - Reply
著者:: Shipman, C, 等
出版事項: (2001)

The role of host microenvironment in the pathogenesis of multiple myeloma
著者:: Lwin, STS
出版事項: (2014)

Testing novel therapies for the treatment of multiple myeloma
著者:: Tosun, C
出版事項: (2023)

Enzymatic Blockade of the Ubiquitin-Proteasome Pathway
著者:: Ernst, Robert, 等
出版事項: (2011)

Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells.
著者:: Ovaa, H, 等
出版事項: (2004)